Patent Re-Exam Discovery Barred, Abbott Tells Fed. Circ.
Abbott Laboratories urged the Federal Circuit on Friday to reject an argument by Johnson & Johnson's Cordis Corp. unit that discovery should be allowed in inter partes patent re-examinations, arguing that...To view the full article, register now.
Already a subscriber? Click here to view full article